TRex Bio, Inc. (TRXB)
NASDAQ: TRXB · Real-Time Price · USD
14.25
+1.12 (8.53%)
Nov 11, 2026, 4:00 PM EST - Market closed

TRex Bio Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, TRex Bio stock has a consensus rating of "Strong Buy" and an average price target of $29.25. The average 1-year stock price forecast is 105.26% higher than the current stock price, while the lowest is $20 (+40.35%) and the highest is $39 (+173.68%).

Price Target: $29.25 (+105.26%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$20$29.25$29$39
Change+40.35%+105.26%+103.51%+173.68%

Analyst Ratings

The average analyst rating for TRex Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingNov '26
Strong Buy4
Buy1
Hold0
Sell0
Strong Sell0
Total5

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$31
BuyInitiates$31+117.54%Nov 3, 2026
J.P. Morgan
J.P. Morgan
Buy
Initiates
$20
BuyInitiates$20+40.35%Nov 3, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Initiates
$39
BuyInitiates$39+173.68%Nov 3, 2026
Wedbush
Wedbush
Buy
Initiates
$30
BuyInitiates$30+110.53%Nov 2, 2026

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.42
EPS Next Year
-1.72
from -2.42
Fiscal YearFY 2024FY 2025FY 2026
Period EndingDec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
39.11M--
Operating Income
-2.38M-37.85M-63.16M
Net Income
-3.14M-34.81M-60.02M
EPS
---2.42
Free Cash Flow
---65.00M
No. Analysts
--4
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-2.00
Avg-2.42
Low-2.84

EPS Growth

EPS Growth20272028
High-
Avg-
Low-